We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01336686
Recruitment Status : Completed
First Posted : April 18, 2011
Last Update Posted : April 17, 2015
Sponsor:
Information provided by (Responsible Party):
CymaBay Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2011
  Study Completion Date : November 2011
  Certification or Request for Extension to Delay Results Submission: February 19, 2015